MOTS-c Makati: The Post-Panel Order

The Makati MOTS-c buyer is a specific animal. Finance, consulting or senior corporate, thirty-five to fifty, living in a tower inside walking distance of the office, and already paying for an annual executive check-up that most of the country never sees. Somewhere in that panel a fasted insulin came back higher than they expected, or the HbA1c crept, and instead of accepting the standard advice they went looking for a mechanism.

MOTS-c is what that search finds. It is the compound that shows up when you type mitochondrial and insulin sensitivity into the same query and read past the supplement results. It is genuinely elegant on paper: a peptide encoded inside the mitochondrial genome, signalling backwards to the nucleus, activating AMPK. For a numerate reader who has just been told their metabolism is drifting, that reads like an answer.

The uncomfortable part of my job in this district is telling people that the elegance is not the same as the evidence, and that the panel they have in their hand is the more valuable object than the vial they are about to buy. Makati readers usually take that well, because they are used to distinguishing a thesis from a result.

Makati has the highest concentration of hospital pharmacies in the country and for MOTS-c that counts for precisely nothing. There is no registration with FDA Philippines, no approved product anywhere in the world, and therefore nothing to prescribe. Mercury Drug along Ayala does not stock it and cannot order it. Neither can Watsons. What either will sell you is bacteriostatic water and a box of 31g insulin syringes, and that is the entire retail pharmacy contribution to a MOTS-c protocol.

The hospital layer is worth paying for anyway, just for a different product. Makati Medical Center’s endocrinology service and outpatient lab run the panels that make a MOTS-c decision informed rather than decorative: fasted glucose, HbA1c, fasted insulin for the HOMA-IR calculation, and a lipid panel. Run them before an eight-week block and again after. That is the discipline that separates a self-experiment from a purchase.

The wider hospital and clinic landscape across the district is covered in our Makati city guide.

Makati towers run the most formalised parcel process in the metro, and for once that process is not the thing you need to manage. MOTS-c ships as lyophilized powder in a sealed vial. Dry is the durable state. A parcel that lands in a Salcedo package room at half past one and gets collected at nine in the evening because you were in a client meeting is, on this compound, a nuisance rather than a write-off.

The fragile object in a Makati MOTS-c protocol is not the delivery. It is the reconstituted vial afterwards, which wants 2 to 8 degrees, an insulated pouch whenever it travels, and disposal at fourteen days. In a condo with a decent fridge that is easy. Reconstitute one vial at a time, keep the rest dry and sealed, and do not store it in the door shelf where the temperature swings every time somebody wants a drink.

This is the section Makati readers actually came for, so here it is without softening.

MOTS-c was identified in 2015 by Lee and Cohen at USC. The preclinical literature covers AMPK activation and effects on obesity and insulin resistance in rodent models, nuclear translocation under metabolic stress in cell work, thermogenic activation of adipose tissue in rodents, and characterisation as an exercise-induced regulator of age-dependent physical decline in mice. Aged mice given MOTS-c performed better on exercise measures. That is a real and interesting finding.

It is also a mouse. No human efficacy data supports improved insulin sensitivity, fat oxidation, body composition or physical capacity in people. Human work on MOTS-c is early and has not delivered efficacy readouts. Set that against the compound at the other end of this site: retatrutide has Jastreboff NEJM 2023 reporting 24.2 percent mean weight reduction at 48 weeks in humans. That is what a human result looks like. MOTS-c does not have one, and a Makati reader who is comfortable distinguishing a promising asset from a proven one should apply exactly that filter here.

My position, for what it is worth: if your panel came back with a genuine insulin problem, the intervention with the strongest human evidence is still the unglamorous one. If you are going to run MOTS-c anyway, run it as an experiment with a pre and post panel, not as a treatment.

The vial figure is a national survey number, not a Makati one. The line that matters is the one it implies: two doses per 10mg vial means a three-times-weekly protocol burns roughly one and a half vials a week, and an eight-week block at that frequency needs about twelve vials. Work it out at the range above before you commit, because on a Makati salary the number is affordable and on any evidence base it is difficult to justify. The metro hub runs the full block arithmetic.

One editorial note that applies everywhere and is worth repeating to a district that buys quickly: demand a third-party certificate of analysis per batch from whoever you buy from, and check the batch number on the paperwork against the number printed on the vial. On a compound this obscure, identity verification is not paranoia. It is the only thing standing between you and an expensive vial of something else.